The magnitude of the problem of chronic diseases (NCDs) in India is substantial and is growing
{source}<iframe class="vid" width="560" height="315" src="//www.youtube.com/embed/UTGaipaU6f8" frameborder="0"…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Express Pharma hosts Idea Exchange with Dr Kenneth Thorpe on prevention of NCDs
Dr Shashank Joshi, President, Indian Diabetic Association and Dr Ratna Devi, CEO, DakshamA Health & Education were also part…
‘We will bring significant value to our customers to help us grow quickly’
GVK Biosciences has recently unveiled a new brand Clinogent in the clinical development industry. Its distinctive approach comes…
Need for HEOR in India: An overview
Dr Amit Dang, Founder and CEO, MarksMan Healthcare Solutions elaborates on concepts like HEOR, HTA, pharmacoeconomics, and gives…
Counting on Research
Indian pharmaceutical companies are putting extra efforts into research-led innovation. But they feel their efforts deserve more…
Safety for Success
Ensuring safety norms are followed in laboratories is one of the crucial criteria for pharmaceutical companies to bag a Good…
‘Our strategy is to develop vaccines with better protection at lower cost’
With the rotavirus and cholera vaccines programmes reaching an important milestone by this year end, Dr Davinder Gill, Chief…
Suven Life Sciences secures product patents
Patents from Australia and Eurasia correspond to the NCEs for the treatment of disorders associated with neurodegene-rative…
DCG(I) plans IT-enabled system for fast CT approvals
Seeks stakeholders' suggestions/comments within three weeks